A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma

Clinical trial NCT06097975 · RECRUITING

Trial details

NCT number: NCT06097975
Sponsor: Universitair Ziekenhuis Brussel
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Glioblastoma

Start date: 2024-03-15
Primary completion: 2025-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.